19q13.11 microdeletion concomitant with ins (2;19)(p25.3;q13.1q13.4)dn in a boy: Potential role of UBA2 in the associated phenotype

Molecular Cytogenetics

Volumn 7, Issue 1, 2014, Pages

  Venegas Vega, Carlos ^a,b   Nieto Martínez, Karem ^b   Martínez Herrera, Alejandro ^b   Gómez Laguna, Laura ^a   Berumen, Jaime ^a,b   Cervantes, Alicia ^a,b   Kofman, Susana ^a,b   Fernández Ramírez, Fernando ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

19q13.11 microdeletion syndrome; Chromosomal rearrangement; Uba2

Indexed keywords

19Q13.11 MICRODELETION SYNDROME; ARTICLE; CASE REPORT; CESAREAN SECTION; CHILD; CHROMOSOME 19Q; CHROMOSOME 2P; CHROMOSOME DISORDER; CHROMOSOME REARRANGEMENT; CLUBFOOT; DEVELOPMENTAL DISORDER; FEBRILE CONVULSION; FEEDING DIFFICULTY; GENE; GENETIC ASSOCIATION; GESTATIONAL AGE; HIP DISLOCATION; HUMAN; HYPOSPADIAS; INGUINAL HERNIA; KARYOTYPE 46,XY; MALE; MICROARRAY ANALYSIS; ORCHIDOPEXY; PHENOTYPE; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; UBA2 GENE; UPPER RESPIRATORY TRACT INFECTION;

EID: 84989311431     PISSN: None     EISSN: 17558166     Source Type: Journal    
DOI: 10.1186/s13039-014-0061-z     Document Type: Article

References (18)

1. Kulharya AS, Michaelis RC, Norris KS, Taylor HA, Garcia-Heras J: Constitutional del (19)(q12q13.1) in a three-year-old girl with severe phenotypic abnormalities affecting multiple organ systems. Am J Med Genet 1998, 77:391-394.
2. Malan V, Raoul O, Firth HV, Royer G, Turleau C, Bernheim A, Willatt L, Munnich A, Vekemans M, Lyonnet S, Cormier-Daire V, Colleaux L: 19q13.11 deletion syndrome: A novel clinically recognisable genetic condition identified by array comparative genomic hybridisation. J Med Genet 2009, 46:635-640.
3. Schuurs-Hoeijmakers JH, Vermeer S, van Bon BW, Pfundt R, Marcelis C, de Brouwer AP, de Leeuw N, de Vries BB: Refining the critical region of the novel 19q13.11 microdeletion syndrome to 750 Kb. J Med Genet 2009, 46:421-423.
4. Gana S, Veggiotti P, Sciacca G, Fedeli C, Bersano A, Micieli G, Maghnie M, Ciccone R, Rossi E, Plunkett K, Bi W, Sutton VR, Zuffardi O: 19q13.11 cryptic deletion: description of two new cases and indication for a role of WTIP haploinsufficiency in hypospadias. Eur J Hum Genet 2012, 20:852-856.
5. Lin SY, Lee CN, Chen TC, Tu MP, Lin CY, Chang TY, Su YN: A fetus with 19q13.11 microdeletion presenting with intrauterine growth restriction and multiple cystic kidney. Case Rep Perinat Med 2012, 1:69-74.
6. Forzano F, Napoli F, Uliana V, Malacarne M, Viaggi C, Bloise R, Coviello D, Di Maria E, Olivieri I, Di Iorgi N, Faravelli F: 19q13 microdeletion syndrome: Further refining the critical region. Eur J Med Genet 2012, 55:429-432.
7. Chowdhury S, Bandholz AM, Parkash S, Dyack S, Rideout AL, Leppig KA, Thiese H, Wheeler PG, Tsang M, Ballif BC, Shaffer LG, Torchia BS, Ellison JW, Rosenfeld JA: Phenotypic and molecular characterization of 19q12q13.1 deletions: A report of five patients. Am J Med Genet A 2014, 164:62-69.
8. Bragin E, Chatzimichali EA, Wright CF, Hurles ME, Firth HV, Bevan AP, Swaminathan GJ: DECIPHER: database for the interpretation of phenotype-linked plausibly pathogenic sequence and copy-number variation. Nucleic Acids Res 2014, 42:D993-D1000.
9. Nowick K, Hamilton AT, Zhang H, Stubbs L: Rapid sequence and expression divergence suggest selection for novel function in primate-specific KRAB-ZNF genes. Mol Biol Evol 2010, 27:2606-2617.
10. Jackson B, Thompson D, Wright M, McAndrews M: Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily. Hum Genomics 2011, 5:691-702.
11. Huang N, Lee I, Marcotte EM, Hurles ME: Characterising and predicting haploinsufficiency in the human genome. Plos Genet 2010, 6:e1001154.
12. Shaikh TH, Gai X, Perin JC, Glessner JT, Xie H, Murphy K, O'Hara R, Casalunovo T, Conlin LK, D'Arcy M, Frackelton EC, Geiger EA, Haldeman- Englert C, Imielinski M, Kim CE, Medne L, Annaiah K, Bradfield JP, Dabaghyan E, Eckert A, Onyiah CC, Ostapenko S, Otieno FG, Santa E, Shaner JL, Skraban R, Smith RM, Elia J, Goldmuntz E, Spinner NB, et al: High-resolution mapping and analysis of copy number variations in the human genome: A data resource for clinical and research applications. Genome Res 2009, 19:1682-1690.
13. MacDonald JR, Ziman R, Yuen RK, Feuk L, Scherer SW: The Database of Genomic Variants: A curated collection of structural variation in the human genome. Nucleic Acids Res 2014, 42:D986-D992.
14. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, Jensen LJ: STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 2013, 41:D808-D815.
15. Ulrich HD: The SUMO system: An overview. Methods Mol Biol 2009, 497:3-16.
16. Mukherjee S, Cruz-Rodríguez O, Bolton E, Iñiguez-Lluhí JA: The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs. J Biol Chem 2012, 287:31195-31206.
17. Komatsu T, Mizusaki H, Mukai T, Ogawa H, Baba D, Shirakawa M, Hatakeyama S, Nakayama KI, Yamamoto H, Kikuchi A, Morohashi K: Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. Mol Endocrinol 2004, 18:2451-2462.
18. Gwizdek C, Cassé F, Martin S: Protein sumoylation in brain development, neuronal morphology and spinogenesis. Neuromolecular Med 2013, 15:677-691.